English | Español
Nicholas Gueguen | Aug 13, 2017

Orexigen Therapeutics teams with Cheplapharm Arzneimittel GmbH to put Mysimba on German, Austrian and French markets
Nicholas Gueguen | Aug 13, 2017

Study finds high school athletes who play only one sport more likely to suffer lower-extremity injuries
Nicholas Gueguen | Aug 13, 2017

Vanderbilt University Eye Institute says to keep eyes protected during solar eclipse
Nicholas Gueguen | Aug 13, 2017

Vanderbilt University task force to use survey to help fight doctor burnout
Nicholas Gueguen | Aug 13, 2017

Yale New Haven paired kidney exchange involves 18 patients
Nicholas Gueguen | Aug 13, 2017

University of Pittsburgh Medical Center Jameson has new outpatient facility
Kacie Whaley | Aug 13, 2017

House panel discusses Special Needs Plans under Medicare Advantage
Nicholas Gueguen | Aug 13, 2017

House Appropriations Committee decides to keep funding for several programs in HIV, hepatitis fight

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’